Paper27872155
Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.
International Hypoglycaemia Study Group. Diabetes Care, 2017. Cited by 502 papers, by iCite.
Cite this record
ConductScience Library. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Papers, record 27872155. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27872155
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05147324 | "MyPlan" - Individualized Planned Eating Patterns for Adolescents With Type 1 Diabetes | Background |
Source ClinicalTrials.gov
Cited by299
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 502 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953185 | Forecasting accuracy is not enough: safety-oriented evaluation of neural digital twins prior to in-silico insulin and carbohydrate intervention in type 1 diabetes. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42953185 | PubMed |
| 42928846 | IcoSema in Weight Management and Glycaemic Control: A Systematic Review and Meta-Analysis. | Cureus | 2026 | https://conductscience.org/library/papers/42928846 | PubMed |
| 42851710 | Implementing a multi-centre hypoglycaemia management surveillance model through a co-designed approach to develop actionable insights in the UK. | Front Health Serv | 2026 | https://conductscience.org/library/papers/42851710 | PubMed |
| 42802751 | Incretin-based injectable strategies versus intensified insulin for treatment intensification and simplification in type 2 diabetes: a systematic review and meta-analysis. | J Diabetes Metab Disord | 2026 | https://conductscience.org/library/papers/42802751 | PubMed |
| 42755124 | Sensor-Detected Hypoglycaemia Is Associated With Inflammatory Protein and Immune Cell Alterations in People With Diabetes: Findings From the Hypo-METRICS Study. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42755124 | PubMed |
| 42720752 | Preserving beta cell function in children and adolescents with newly diagnosed stage 3 type 1 diabetes: per-protocol population analysis from the PROTECT randomised trial. | Diabetologia | 2026 | https://conductscience.org/library/papers/42720752 | PubMed |
| 42633369 | Impact of pre-arrest glycemic state induced by prolonged fasting on defibrillation requirements: a prospective porcine model of ventricular fibrillation cardiac arrest. | Resusc Plus | 2026 | https://conductscience.org/library/papers/42633369 | PubMed |
| 42554785 | Glycemic Patterns Assessed by Continuous Glucose Monitoring in People with Type 2 Diabetes Treated with Insulin Glargine 100 U/mL in Primary Care: The GPDetect Study. | Diabetes Ther | 2026 | https://conductscience.org/library/papers/42554785 | PubMed |
| 42552225 | Factors Associated With Progression From Level 1 to Level 2 Sensor-Detected Hypoglycaemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: A Post Hoc Analysis From the Hypo-METRICS Study. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42552225 | PubMed |
| 42473259 | Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42473259 | PubMed |
| 42410316 | Real-World Effectiveness and Safety of Tirzepatide in Type 1 Diabetes and Obesity: Impact on Glycaemia, Weight, and Cardiometabolic Risk Markers. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42410316 | PubMed |
| 42240322 | The impact of perioperative fasting on metabolic status in elective caesarean section patients. | S Afr Fam Pract (2004) | 2026 | https://conductscience.org/library/papers/42240322 | PubMed |
| 42203212 | A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42203212 | PubMed |
| 42162480 | [Hospital diabetes management (Update 2026)]. | Wien Klin Wochenschr | 2026 | https://conductscience.org/library/papers/42162480 | PubMed |
| 42142068 | Clinical and Metabolic Predictors of Cognitive Impairment in Type 1 Diabetes: The Role of Peripheral Neuropathy and Hypoglycaemia Unawareness. Findings From a HAD-1 Study. | Diabetes Metab Res Rev | 2026 | https://conductscience.org/library/papers/42142068 | PubMed |
| 42010787 | Clinically significant hypoglycaemia in hospitalised adults: A multicentre study of 1205 episodes in the United Kingdom. | Diabet Med | 2026 | https://conductscience.org/library/papers/42010787 | PubMed |
| 41906206 | Exploring the gap between sensor-detected (SDH) and person-reported hypoglycaemia (PRH): The voice of people living with diabetes. | Diabet Med | 2026 | https://conductscience.org/library/papers/41906206 | PubMed |
| 41896513 | Euglycemic Diabetic Ketoacidosis Treatment Protocol With Increased Dextrose Supplementation to Prevent Hypoglycemia. | Acad Emerg Med | 2026 | https://conductscience.org/library/papers/41896513 | PubMed |
| 41852263 | Artificial Intelligence in Type 1 Diabetes Management: A Scoping Review of Randomised Controlled Trials. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/41852263 | PubMed |
| 41724265 | A pilot trial of 'HypoPals': Assessing trial procedures feasibility and intervention acceptability for a prospective digital hypoglycemia behavioral intervention study. | Contemp Clin Trials | 2026 | https://conductscience.org/library/papers/41724265 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27872155
GET https://conductscience.org/api/papers/v1/27872155/cited_by?page=2